SSP

Two new SSPs issued for Estraderm MX® patches

The Department of Health and Social Care (DHSC) has issued two Serious Shortage Protocols for Estraderm MX® 50 microgram and 75 microgram patches in response to a significant ongoing supply disruption.

SSP037 for Estraderm MX® 50 microgram patch will be in operation from Tuesday 15th November 2022 until Friday 13th January 2023.

It allows Evorel® 50 microgram patches to be supplied against prescriptions for Estraderm MX® 50 microgram patches.

Learn more

SSP038 for Estraderm MX® 75 microgram patch will be in operation from Tuesday 15th November 2022 until Friday 13th January 2023.

It allows Evorel® 75 microgram patches to be supplied against prescriptions for Estraderm MX® 75 microgram patches.

Learn more

There are no SSPs in place for Estraderm MX® 25mcg patches and 100mcg patches as these strengths are no longer affected by supply disruptions and should continue to be dispensed in accordance with the prescriptions.

The SSP037 and SSP038 only allow substitution of Estraderm MX®50 or 75 patches with Evorel® 50 or 75 patches, respectively and do not allow for the quantity supplied to be less than that prescribed.

The supervising pharmacist should ensure that the patient’s prescriber is notified when supplying a patient in accordance with these SSPs